Life Science Invest
VC Fund
Bromma, Sweden
Life Science Invest is an investment firm that specializes in investment in the field of healthcare digital services and Medtech.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Life Science Invest invests in
Stages Life Science Invest invests in
Countries Life Science Invest invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $682k–$4.6M
- Pre-Seed
- $310k–$500k
Investment Focus
Industry
- Medical 2 (33%)
- Biotechnology 2 (33%)
- Biopharma 1 (17%)
- Medical Device 1 (17%)
- Pharmaceutical 1 (17%)
Stage
- Seed 4 (67%)
- Pre-Seed 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Kristofer Klerfalk
Co-Founder, CEO and Board Member
|
Co-Founder, CEO and Board Member | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Haga Bioscience is a biotechnology research company. | $2.2M / Seed / Jun 03, 2026 | ||
| Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery. | $4.6M / Seed / Feb 17, 2026 | ||
| Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection. | $1.8M / Seed / May 09, 2025 | ||
| AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies. | $681.9K / Seed / Oct 02, 2024 | ||
| MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins. | $500K / Pre-Seed / Mar 03, 2024 | ||
| MedVasc has developed Solution a patented medical device that reduces pain when treating varicose veins. | $310K / Pre-Seed / Mar 03, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Life Science Invest invest in?
Life Science Invest invests primarily in Medical, Biotechnology and Biopharma startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in Sweden. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Life Science Invest's check size?
Life Science Invest typically joins rounds of $682k–$4.6M at Seed and $310k–$500k at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Life Science Invest participates in.
How do I contact Life Science Invest?
Public channels for Life Science Invest include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Life Science Invest?
The team at Life Science Invest includes Kristofer Klerfalk (Co-Founder, CEO and Board Member). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
